Dr. James Rouse Appointed as Chief Lifestyle Medical Officer and Vice Chairman of Scientific Advisory Board at Vital Living Inc.

PHOENIX, May 26, 2004 (BUSINESS WIRE) --

Noted Naturopathic Physician, Entrepreneur, TV Personality and Trainer
to Help Promote Awareness of Company's Expanding Product Lines of
Healthy Foods and Nutritional/Dietary Supplements


Vital Living Inc. (VTLV) today announced the appointment of Dr. James Rouse, nationally renowned naturopathic physician, as vice chairman of the company's scientific advisory board and as its chief lifestyle medical officer.

Rouse's extensive credentials in the wellness field include a doctorate degree in naturopathic medicine, post-doctorate work in acupuncture and Chinese medicine, a degree in transpersonal psychology and certification as a yoga teacher. He combines his knowledge of natural medicine, transformational psychology, yoga and therapeutic cooking to inspire people to improve the quality of their lives and to provide them with the tools they need to make positive, healthy changes.

Rouse owns and operates a naturopathic family practice clinic in Denver, and hosts two Optimum Wellness news segments, "Wellness Wednesday" and "The Fit Kitchen," which air weekly in the Denver, Los Angeles, Seattle, Salt Lake City and Phoenix markets. Aside from being a sponsored Ironman triathlete, Rouse is also the founder, chairman and chief medical officer of Envitalment Inc., a wellness and performance coaching, training and consulting company; president and CEO of Be Alive & Well Inc.; and director of coordinated care and complementary medicine at the Phoenix Center for Health Excellence.

Stuart A. Benson, chief executive officer of Vital Living, stated, "Dr. Rouse uniquely personifies Vital Living's values, business practices and corporate philosophies. There is no question that he will prove to be a valuable asset and a noted ally in our quest to promote Vital Living's nutritional products and solutions to a broader audience of health-conscious individuals. We are delighted to welcome Dr. Rouse to our management team and scientific advisory board and expect that the prestige and national distinction he brings to Vital Living will further strengthen our position as an emerging leader in the healthcare industry."

About Vital Living Inc.

Headquartered in Phoenix, Vital Living develops or licenses nutraceuticals and pharmaceuticals and markets them for distribution through physicians, medical groups, chiropractic offices and retail outlets. Vital Living develops and tests its nutraceuticals in collaboration with leading medical experts in the nutraceuticals field and has designed them to be incorporated by physicians into a standard physician-patient program in which patients supplement doctor-prescribed pharmaceuticals with its nutraceuticals.

Vital Living provides unique, safe and naturally derived nutritional products, utilizing advanced drug-delivery technologies, including the Geomatrix(R) technology through its affiliation with SkyePharma PLC. The Geomatrix(R) technology has been provided exclusively for Vital Living's pharmaceutical development in China, and the development of nutraceuticals. The company's initial areas of focus are cardiovascular health, through its product Essentum(R) which is currently undergoing clinical trials and being endorsed by the Arizona Heart Institute and prescribed throughout the United States, and weight loss, through its licensed product X-Fat(R), the company's patented dietary supplement that uses Kytabsorbe, a liquid form of the natural fat absorber, Chitosan. Vital Living also owns and operates three wholly owned subsidiaries: MAF BioNutritionals, Christopher's Herbal Formulas and Doctors for Nutrition. For more information on the company, please visit www.vitalliving.com.

Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties, including activities, events or developments that the company expects, believes or anticipates will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the company's ability to continue to successfully market and provide its products and services and maintain their effectiveness, the continuation of the arrangements with the company's product development partners, the ability of the company to meet its financial projections, and general economic conditions. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish